Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Colombiana de Cardiología
Print version ISSN 0120-5633
Abstract
HERRERA-LEANO, Nancy et al. Frequency and geographical distribution of the use of sacubitril/valsartan in Colombia between 2019 and 2020. Rev. Colomb. Cardiol. [online]. 2024, vol.31, n.1, pp.12-18. Epub Mar 07, 2024. ISSN 0120-5633. https://doi.org/10.24875/rccar.22000008.
Introduction:
Real-life adherence to the management of heart failure is suboptimal. Adherence to the recommendations for the use of sacubitril/valsartan in Colombia is unknown.
Objective:
To assess the frequency of use, geographic distribution, and demographic characteristics of patients who were prescribed sacubitril/valsartan in 2019-2020, using data from the “Sistema Integrado de Información de Protección Social” (SISPRO).
Materials and method:
This is a descriptive cross-sectional study. Information was extracted on the prescription distribution by department, gender, five-year age groups and the ICD-10 codes with which the medication was prescribed.
Results:
Between 2019 and 2020, 23,026 patients in Colombia were prescribed sacubitril/valsartan; 63.86% of the patients were men. Ninety-two percent of the prescriptions were for patients over the age of 50. The regions of the country with the highest prescription frequency were Bogotá, Sucre and Santander.
Conclusions:
Taking into account the estimated prevalence of heart failure (2-3%), the frequency with which sacubitril/valsartan is prescribed in Colombia is lower than expected. The rural regions of the country have the lowest use, which suggests access barriers that should be explored.
Keywords : Sacubitril/valsartan; Heart failure; Colombia.